BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31611629)

  • 1. Treatment and outcome of IG-MYC
    Herbrueggen H; Mueller S; Rohde J; Arias Padilla L; Moericke A; Attarbaschi A; Zimmermann M; Ratei R; Brueggemann M; Siebert R; Goehring G; Schlegelberger B; Bradtke J; Klapper W; Woessmann W; Burkhardt B
    Leukemia; 2020 Mar; 34(3):942-946. PubMed ID: 31611629
    [No Abstract]   [Full Text] [Related]  

  • 2. IG-
    Wagener R; López C; Kleinheinz K; Bausinger J; Aukema SM; Nagel I; Toprak UH; Seufert J; Altmüller J; Thiele H; Schneider C; Kolarova J; Park J; Hübschmann D; Murga Penas EM; Drexler HG; Attarbaschi A; Hovland R; Kjeldsen E; Kneba M; Kontny U; de Leval L; Nürnberg P; Oschlies I; Oscier D; Schlegelberger B; Stilgenbauer S; Wössmann W; Schlesner M; Burkhardt B; Klapper W; Jaffe ES; Küppers R; Siebert R
    Blood; 2018 Nov; 132(21):2280-2285. PubMed ID: 30282799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric precursor B-cell acute lymphoblastic leukemia with MYC 8q24 translocation - how to treat?
    Zhang C; Amos Burke GA
    Leuk Lymphoma; 2018 Aug; 59(8):1807-1813. PubMed ID: 29022749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan.
    Sakaguchi K; Imamura T; Ishimaru S; Imai C; Shimonodan H; Fujita N; Okada K; Taketani T; Kanai R; Tauchi H; Kato M; Kojima Y; Watanabe A; Deguchi T; Hashii Y; Kiyokawa N; Taki T; Saito AM; Horibe K; Manabe A; Sato A; Koh K
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28341. PubMed ID: 32323914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.
    Li Y; Gupta G; Molofsky A; Xie Y; Shihabi N; McCormick J; Jaffe ES
    Am J Surg Pathol; 2018 Feb; 42(2):269-276. PubMed ID: 29112016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance?
    Allen A; Gill K; Hoehn D; Sulis M; Bhagat G; Alobeid B
    Leuk Res; 2014 Sep; 38(9):1061-6. PubMed ID: 25060305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis.
    Liu W; Hu S; Konopleva M; Khoury JD; Kalhor N; Tang G; Bueso-Ramos CE; Jorgensen JL; Lin P; Medeiros LJ; Lu X
    Pediatr Hematol Oncol; 2015; 32(8):535-47. PubMed ID: 26558423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining clinical risk classification in children with precursor B cell acute lymphoblastic leukemia using pre-treatment absolute lymphocyte count.
    Fungpipat P; Sophonphan J; Sosothikul D; Suppipat K
    Leuk Lymphoma; 2016; 57(4):953-6. PubMed ID: 26292611
    [No Abstract]   [Full Text] [Related]  

  • 11. A pediatric B lineage leukemia with coincident MYC and MLL translocations.
    Meeker ND; Cherry AM; Bangs CD; Frazer JK
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):158-60. PubMed ID: 20829716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial.
    Wayne AS; Kreitman RJ; Findley HW; Lew G; Delbrook C; Steinberg SM; Stetler-Stevenson M; Fitzgerald DJ; Pastan I
    Clin Cancer Res; 2010 Mar; 16(6):1894-903. PubMed ID: 20215554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13.
    Subramaniyam S; Fraser CR; Rao PH; Feldman E; Ely S; Mathew S
    Leuk Lymphoma; 2011 Nov; 52(11):2195-9. PubMed ID: 21718139
    [No Abstract]   [Full Text] [Related]  

  • 14. B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature.
    Sajaroff EO; Mansini A; Rubio P; Alonso CN; Gallego MS; Coccé MC; Eandi-Eberle S; Bernasconi AR; Ampatzidou M; Paterakis G; Papadhimitriou SI; Petrikkos L; Papadakis V; Polychronopoulou S; Rossi JG; Felice MS
    Leuk Lymphoma; 2016 Oct; 57(10):2289-97. PubMed ID: 26857438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia.
    Coyaud E; Struski S; Dastugue N; Brousset P; Broccardo C; Bradtke J
    Leuk Res; 2010 Dec; 34(12):e323-5. PubMed ID: 20723977
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding the reconstitution of the B-cell compartment in bone marrow and blood after treatment for B-cell precursor acute lymphoblastic leukaemia.
    Theunissen PMJ; van den Branden A; Van Der Sluijs-Gelling A; De Haas V; Beishuizen A; van Dongen JJM; Van Der Velden VHJ
    Br J Haematol; 2017 Jul; 178(2):267-278. PubMed ID: 28542787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell Lymphomas.
    Otto C; Scholtysik R; Schmitz R; Kreuz M; Becher C; Hummel M; Rosenwald A; Trümper L; Klapper W; Siebert R; Küppers R;
    Genes Chromosomes Cancer; 2016 Dec; 55(12):932-943. PubMed ID: 27356265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.
    Boström H; Leuchowius KJ; Hallböök H; Nordgren A; Thörn I; Thorselius M; Rosenquist R; Söderberg O; Sundström C
    Eur J Haematol; 2008 Sep; 81(3):218-25. PubMed ID: 18510704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
    Troeger A; Gudowius S; Escherich G; den Boer ML; Glouchkova L; Ackermann B; Meisel R; Laws HJ; Groeger M; Wessalowski R; Willers R; Harbott J; Pieters R; Goebel U; Janka-Schaub GE; Hanenberg H; Dilloo D
    Br J Haematol; 2007 Nov; 139(3):450-7. PubMed ID: 17910636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.